[Special Lecture by Professor Yuji Ito, Kagoshima University] Next-Generation Drug Discovery Using DDS with Organ-Targeting Antibodies - AccumBody Platform and Antibody Conjugate Technology -
Agilent Seminar / Connecting ADC Analysis - An Integrated Workflow from Sample Preparation to Quality Assessment
[Special Lecture]
Next-Generation Drug Discovery Using DDS with Organ-Targeting Antibodies - AccumBody Platform and Antibody Conjugate Technology -
Professor Yuji Ito, Graduate School of Science and Engineering, Kagoshima University
We are pleased to announce a seminar focusing on analytical challenges in the research, development, and quality control of biopharmaceuticals, particularly antibody-drug conjugates (ADCs). In this seminar, we will welcome Professor Ito from Kagoshima University, who will present the latest analytical strategies and practical insights in biopharmaceutical research, including ADCs. Additionally, Agilent will introduce the following three perspectives in a way that is directly applicable to practice:
- The role and potential of high-resolution MS (QTOF) in biopharmaceutical analysis
- Improved separation performance and reproducibility through consumable solutions for HPLC centered around the Altura column
- An integrated workflow connecting sample preparation automation to MAM, data management, and regulatory compliance
This content goes beyond individual product introductions, providing an overview of the entire process from sample preparation to analysis and quality assessment.

| Date and time | Wednesday, Jul 15, 2026 01:00 PM ~ 05:20 PM |
|---|---|
| Capital | Shinagawa Front Building Conference Room B 〒108-0075 2-3-13 Konan, Minato-ku, Tokyo Shinagawa Front Building, B1 Floor |
| Entry fee | Free |
Inquiry about this news
Contact Us OnlineMore Details & Registration
Details & Registration



